The number of ADRs associated with hydroxychloroquine and chloroquine more than doubled in 2020 compared with 2018 and 2019.
The approval was based on data from the pivotal phase 3 AURORA and phase 2 AURA-LV studies.
In this case study, the authors highlighted the importance of tuberculous arthritis in the differential diagnoses of patients with persistent ankle swelling.
Researchers presented a text mining algorithm to assess the diagnosis and characteristics of patients with systemic lupus erythematosus.
Based on new findings from a study of patients with systemic lupus erythematosus, investigators suggest revising current guidelines to expand kidney biopsy indications to include isolated proteinuria of any grade.
The estimated prevalence of systemic lupus erythematosus (SLE) in the United States is 72.8/100,000.
A survey from the Lupus Research Alliance announced that two-thirds of people with lupus are willing to receive a COVID-19 vaccine.
Researchers identified predictors of osteonecrosis in patients with systemic lupus erythematosus.
For patients with SLE lower hydroxychloroquine blood levels are associated with a higher risk for thrombotic events.
Researchers evaluated the safety, mechanism of action, and preliminary efficacy of rituximab and cyclophosphamide followed by belimumab in the treatment of refractory lupus nephritis.